Copyright Reports & Markets. All rights reserved.

Global Biotherapeutics Cell Line Development Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Biotherapeutics Cell Line Development Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Biotherapeutics Cell Line Development Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Transfection & Selection
    • 1.4.3 Single Cell Cloning
  • 1.5 Market by Application
    • 1.5.1 Global Biotherapeutics Cell Line Development Market Share by Application: 2020 VS 2026
    • 1.5.2 In-house
    • 1.5.3 Outsource
    • 1.5.4 Hybrid
    • 1.5.5 Do-It-Yourself (DIY)
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Biotherapeutics Cell Line Development Market Perspective (2015-2026)
  • 2.2 Global Biotherapeutics Cell Line Development Growth Trends by Regions
    • 2.2.1 Biotherapeutics Cell Line Development Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Biotherapeutics Cell Line Development Historic Market Share by Regions (2015-2020)
    • 2.2.3 Biotherapeutics Cell Line Development Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Biotherapeutics Cell Line Development Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Biotherapeutics Cell Line Development Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Biotherapeutics Cell Line Development Players by Market Size
    • 3.1.1 Global Top Biotherapeutics Cell Line Development Players by Revenue (2015-2020)
    • 3.1.2 Global Biotherapeutics Cell Line Development Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Biotherapeutics Cell Line Development Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Biotherapeutics Cell Line Development Market Concentration Ratio
    • 3.2.1 Global Biotherapeutics Cell Line Development Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Biotherapeutics Cell Line Development Revenue in 2019
  • 3.3 Biotherapeutics Cell Line Development Key Players Head office and Area Served
  • 3.4 Key Players Biotherapeutics Cell Line Development Product Solution and Service
  • 3.5 Date of Enter into Biotherapeutics Cell Line Development Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Biotherapeutics Cell Line Development Historic Market Size by Type (2015-2020)
  • 4.2 Global Biotherapeutics Cell Line Development Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Biotherapeutics Cell Line Development Market Size by Application (2015-2020)
  • 5.2 Global Biotherapeutics Cell Line Development Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Biotherapeutics Cell Line Development Market Size (2015-2020)
  • 6.2 Biotherapeutics Cell Line Development Key Players in North America (2019-2020)
  • 6.3 North America Biotherapeutics Cell Line Development Market Size by Type (2015-2020)
  • 6.4 North America Biotherapeutics Cell Line Development Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Biotherapeutics Cell Line Development Market Size (2015-2020)
  • 7.2 Biotherapeutics Cell Line Development Key Players in Europe (2019-2020)
  • 7.3 Europe Biotherapeutics Cell Line Development Market Size by Type (2015-2020)
  • 7.4 Europe Biotherapeutics Cell Line Development Market Size by Application (2015-2020)

8 China

  • 8.1 China Biotherapeutics Cell Line Development Market Size (2015-2020)
  • 8.2 Biotherapeutics Cell Line Development Key Players in China (2019-2020)
  • 8.3 China Biotherapeutics Cell Line Development Market Size by Type (2015-2020)
  • 8.4 China Biotherapeutics Cell Line Development Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Biotherapeutics Cell Line Development Market Size (2015-2020)
  • 9.2 Biotherapeutics Cell Line Development Key Players in Japan (2019-2020)
  • 9.3 Japan Biotherapeutics Cell Line Development Market Size by Type (2015-2020)
  • 9.4 Japan Biotherapeutics Cell Line Development Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Biotherapeutics Cell Line Development Market Size (2015-2020)
  • 10.2 Biotherapeutics Cell Line Development Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Biotherapeutics Cell Line Development Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Biotherapeutics Cell Line Development Market Size by Application (2015-2020)

11 India

  • 11.1 India Biotherapeutics Cell Line Development Market Size (2015-2020)
  • 11.2 Biotherapeutics Cell Line Development Key Players in India (2019-2020)
  • 11.3 India Biotherapeutics Cell Line Development Market Size by Type (2015-2020)
  • 11.4 India Biotherapeutics Cell Line Development Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Biotherapeutics Cell Line Development Market Size (2015-2020)
  • 12.2 Biotherapeutics Cell Line Development Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Biotherapeutics Cell Line Development Market Size by Type (2015-2020)
  • 12.4 Central & South America Biotherapeutics Cell Line Development Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Becton Dickinson & Company
    • 13.1.1 Becton Dickinson & Company Company Details
    • 13.1.2 Becton Dickinson & Company Business Overview
    • 13.1.3 Becton Dickinson & Company Biotherapeutics Cell Line Development Introduction
    • 13.1.4 Becton Dickinson & Company Revenue in Biotherapeutics Cell Line Development Business (2015-2020))
    • 13.1.5 Becton Dickinson & Company Recent Development
  • 13.2 Beckman Coulter
    • 13.2.1 Beckman Coulter Company Details
    • 13.2.2 Beckman Coulter Business Overview
    • 13.2.3 Beckman Coulter Biotherapeutics Cell Line Development Introduction
    • 13.2.4 Beckman Coulter Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
    • 13.2.5 Beckman Coulter Recent Development
  • 13.3 Boehringer Ingelheim Group
    • 13.3.1 Boehringer Ingelheim Group Company Details
    • 13.3.2 Boehringer Ingelheim Group Business Overview
    • 13.3.3 Boehringer Ingelheim Group Biotherapeutics Cell Line Development Introduction
    • 13.3.4 Boehringer Ingelheim Group Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
    • 13.3.5 Boehringer Ingelheim Group Recent Development
  • 13.4 Catalent Inc.
    • 13.4.1 Catalent Inc. Company Details
    • 13.4.2 Catalent Inc. Business Overview
    • 13.4.3 Catalent Inc. Biotherapeutics Cell Line Development Introduction
    • 13.4.4 Catalent Inc. Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
    • 13.4.5 Catalent Inc. Recent Development
  • 13.5 CMC Biologics A/S
    • 13.5.1 CMC Biologics A/S Company Details
    • 13.5.2 CMC Biologics A/S Business Overview
    • 13.5.3 CMC Biologics A/S Biotherapeutics Cell Line Development Introduction
    • 13.5.4 CMC Biologics A/S Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
    • 13.5.5 CMC Biologics A/S Recent Development
  • 13.6 Lonza Group Ltd.
    • 13.6.1 Lonza Group Ltd. Company Details
    • 13.6.2 Lonza Group Ltd. Business Overview
    • 13.6.3 Lonza Group Ltd. Biotherapeutics Cell Line Development Introduction
    • 13.6.4 Lonza Group Ltd. Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
    • 13.6.5 Lonza Group Ltd. Recent Development
  • 13.7 EMD Millipore
    • 13.7.1 EMD Millipore Company Details
    • 13.7.2 EMD Millipore Business Overview
    • 13.7.3 EMD Millipore Biotherapeutics Cell Line Development Introduction
    • 13.7.4 EMD Millipore Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
    • 13.7.5 EMD Millipore Recent Development
  • 13.8 Partec (Sysmex Corporation)
    • 13.8.1 Partec (Sysmex Corporation) Company Details
    • 13.8.2 Partec (Sysmex Corporation) Business Overview
    • 13.8.3 Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Introduction
    • 13.8.4 Partec (Sysmex Corporation) Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
    • 13.8.5 Partec (Sysmex Corporation) Recent Development
  • 13.9 ProBioGen AG
    • 13.9.1 ProBioGen AG Company Details
    • 13.9.2 ProBioGen AG Business Overview
    • 13.9.3 ProBioGen AG Biotherapeutics Cell Line Development Introduction
    • 13.9.4 ProBioGen AG Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
    • 13.9.5 ProBioGen AG Recent Development
  • 13.10 Selexis SA
    • 13.10.1 Selexis SA Company Details
    • 13.10.2 Selexis SA Business Overview
    • 13.10.3 Selexis SA Biotherapeutics Cell Line Development Introduction
    • 13.10.4 Selexis SA Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
    • 13.10.5 Selexis SA Recent Development
  • 13.11 Sigma-Aldrich Co. LLC.
    • 10.11.1 Sigma-Aldrich Co. LLC. Company Details
    • 10.11.2 Sigma-Aldrich Co. LLC. Business Overview
    • 10.11.3 Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Introduction
    • 10.11.4 Sigma-Aldrich Co. LLC. Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
    • 10.11.5 Sigma-Aldrich Co. LLC. Recent Development
  • 13.12 Sony Biotechnology Inc.
    • 10.12.1 Sony Biotechnology Inc. Company Details
    • 10.12.2 Sony Biotechnology Inc. Business Overview
    • 10.12.3 Sony Biotechnology Inc. Biotherapeutics Cell Line Development Introduction
    • 10.12.4 Sony Biotechnology Inc. Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
    • 10.12.5 Sony Biotechnology Inc. Recent Development
  • 13.13 Thermo Fisher Scientific Inc.
    • 10.13.1 Thermo Fisher Scientific Inc. Company Details
    • 10.13.2 Thermo Fisher Scientific Inc. Business Overview
    • 10.13.3 Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Introduction
    • 10.13.4 Thermo Fisher Scientific Inc. Revenue in Biotherapeutics Cell Line Development Business (2015-2020)
    • 10.13.5 Thermo Fisher Scientific Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Biotherapeutics Cell Line Development market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biotherapeutics Cell Line Development market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Becton Dickinson & Company
    Beckman Coulter
    Boehringer Ingelheim Group
    Catalent Inc.
    CMC Biologics A/S
    Lonza Group Ltd.
    EMD Millipore
    Partec (Sysmex Corporation)
    ProBioGen AG
    Selexis SA
    Sigma-Aldrich Co. LLC.
    Sony Biotechnology Inc.
    Thermo Fisher Scientific Inc.

    Market segment by Type, the product can be split into
    Transfection & Selection
    Single Cell Cloning
    Market segment by Application, split into
    In-house
    Outsource
    Hybrid
    Do-It-Yourself (DIY)

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now